Home » Stocks » ONVO

Organovo Holdings, Inc. (ONVO)

Stock Price: $15.30 USD 0.93 (6.47%)
Updated Jan 20, 2021 4:00 PM EST - Market closed
After-hours: $15.25 -0.05 (-0.33%) Jan 20, 7:34 PM
Market Cap 99.70M
Revenue (ttm) 298,000
Net Income (ttm) -17.81M
Shares Out 6.57M
EPS (ttm) -2.73
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 20
Last Price $15.30
Previous Close $14.37
Change ($) 0.93
Change (%) 6.47%
Day's Open 14.18
Day's Range 13.61 - 15.70
Day's Volume 403,082
52-Week Range 0.21 - 17.05

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 4 months ago

SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (“Organovo” or the “Company”) (Nasdaq: ONVO) announced today that it has regained compliance with the minimum bid price ...

GlobeNewsWire - 5 months ago

SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (the “Company”) (Nasdaq: ONVO) today announced that it filed a certificate of second amendment to its certificate of inco...

Zacks Investment Research - 1 year ago

As of late, it has definitely been a great time to be an investor in Organovo.

Zacks Investment Research - 1 year ago

Bet on these top-ranked stocks with rising P/E for outsized gains.

Other stocks mentioned: ALXN, AVGR, CYBR, QLYS
Zacks Investment Research - 1 year ago

Organovo (ONVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 1 year ago

Reiterates Commitment to Strategic Review Process Reiterates Commitment to Strategic Review Process

Zacks Investment Research - 1 year ago

Organovo (ONVO) delivered earnings and revenue surprises of 0.00% and -13.13%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Organovo (ONVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 1 year ago

Organovo (ONVO) needs investors to pay close attention to the stock based on moves in the options market lately.

Seeking Alpha - 1 year ago

Organovo Holdings, Inc. (ONVO) CEO Taylor Crouch on Q4 2019 Results - Earnings Call Transcript

About ONVO

Organovo Holdings, a biotechnology company, develops bioprinted human tissues based on its 3D human tissue platform technology that emulate human biology and diseases. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predi... [Read more...]

Industry
Diagnostics & Research
Founded
2007
Stock Exchange
NASDAQ
Ticker Symbol
ONVO
Full Company Profile

Financial Performance

In 2019, ONVO's revenue was $2.20 million, a decrease of -28.96% compared to the previous year's $3.09 million. Losses were -$18.71 million, -29.75% less than in 2018.

Financial Statements